Shawnika J Hull1,2, Hanna Tessema2, Jeri Thuku2, Rachel K Scott3,4,5. 1. Department of Communication, Rutgers University, New Brunswick, NJ. 2. Department of Prevention and Community Health, the George Washington University, Washington, DC. 3. Center for AIDS Prevention Studies, Prevention Research Center, Division of Prevention Science, University of California, California, San Francisco. 4. Women's and Infants' Services Department, MedStar Washington Hospital Center, Washington, DC; and. 5. Georgetown University School of Medicine, Washington, DC.
Abstract
BACKGROUND: Despite their disparately high HIV incidence and voiced willingness to use pre-exposure prophylaxis (PrEP), Black cisgender women's knowledge and uptake of PrEP are low, especially relative to White cisgender women and men who have sex with men. Mounting evidence demonstrates that health care provider recommendations are a critical factor in women's awareness, willingness, and ability to uptake PrEP. Health care providers may make clinical judgments about who is (not) a good candidate for PrEP based on unconscious and conscious stereotypes and prejudice. SETTING: We conducted an online experiment among N = 160 health care providers with prescribing privileges in the 48 HIV hotspot counties. METHOD: Providers received 1 of 4 vignettes about a PrEP eligible woman. Vignettes varied by patient race and substance use status. Then, providers reported their willingness to discuss PrEP with the patient and willingness to prescribe PrEP to her. RESULTS: We tested 2 models predicting providers (1) willingness to discuss and (2) willingness to prescribe PrEP, contingent on their racial attitudes. Providers who scored high on a modern racism measure were less willing to discuss and prescribe PrEP to the Black patient. These effects were mediated by provider perceptions of patients' abilities to adhere to PrEP, but not their expectations of risk compensatory behaviors. CONCLUSIONS: Our findings highlight the importance of applying an intersectional lens in documenting the processes that exacerbate inequities in PrEP use. This study provides evidence to support the development of interventions that address the mechanisms that work to thwart optimal care.
BACKGROUND: Despite their disparately high HIV incidence and voiced willingness to use pre-exposure prophylaxis (PrEP), Black cisgender women's knowledge and uptake of PrEP are low, especially relative to White cisgender women and men who have sex with men. Mounting evidence demonstrates that health care provider recommendations are a critical factor in women's awareness, willingness, and ability to uptake PrEP. Health care providers may make clinical judgments about who is (not) a good candidate for PrEP based on unconscious and conscious stereotypes and prejudice. SETTING: We conducted an online experiment among N = 160 health care providers with prescribing privileges in the 48 HIV hotspot counties. METHOD: Providers received 1 of 4 vignettes about a PrEP eligible woman. Vignettes varied by patient race and substance use status. Then, providers reported their willingness to discuss PrEP with the patient and willingness to prescribe PrEP to her. RESULTS: We tested 2 models predicting providers (1) willingness to discuss and (2) willingness to prescribe PrEP, contingent on their racial attitudes. Providers who scored high on a modern racism measure were less willing to discuss and prescribe PrEP to the Black patient. These effects were mediated by provider perceptions of patients' abilities to adhere to PrEP, but not their expectations of risk compensatory behaviors. CONCLUSIONS: Our findings highlight the importance of applying an intersectional lens in documenting the processes that exacerbate inequities in PrEP use. This study provides evidence to support the development of interventions that address the mechanisms that work to thwart optimal care.
Authors: Mehrit Tekeste; Shawnika Hull; John F Dovidio; Cara B Safon; Oni Blackstock; Tamara Taggart; Trace S Kershaw; Clair Kaplan; Abigail Caldwell; Susan B Lane; Sarah K Calabrese Journal: AIDS Behav Date: 2019-07
Authors: Bisola O Ojikutu; Laura M Bogart; Molly Higgins-Biddle; Sannisha K Dale; Wanda Allen; Tiffany Dominique; Kenneth H Mayer Journal: AIDS Behav Date: 2018-11
Authors: Charlene A Flash; Valerie E Stone; Jennifer A Mitty; Matthew J Mimiaga; Kathryn T Hall; Douglas Krakower; Kenneth H Mayer Journal: AIDS Patient Care STDS Date: 2014-12 Impact factor: 5.078
Authors: Sarah K Calabrese; Valerie A Earnshaw; Douglas S Krakower; Kristen Underhill; Wilson Vincent; Manya Magnus; Nathan B Hansen; Trace S Kershaw; Kenneth H Mayer; Joseph R Betancourt; John F Dovidio Journal: AIDS Behav Date: 2018-04
Authors: Lakshmi Goparaju; Nathan C Praschan; Lari Warren-Jeanpiere; Laure S Experton; Mary A Young; Seble Kassaye Journal: J AIDS Clin Res Date: 2017-09-25
Authors: Amy K Johnson; Maria Pyra; Samantha Devlin; A Ziggy Uvin; Shemeka Irby; Cori Blum; Eric Stewart; Lisa Masinter; Sadia Haider; Lisa R Hirschhorn; Jessica P Ridgway Journal: J Acquir Immune Defic Syndr Date: 2022-07-01 Impact factor: 3.771
Authors: Lila Starbuck; Sarit A Golub; Augustus Klein; Alexander B Harris; Amiyah Guerra; Christopher Rincon; Asa E Radix Journal: J Acquir Immune Defic Syndr Date: 2022-05-01 Impact factor: 3.771
Authors: Hamid Vega-Ramirez; Thiago S Torres; Centli Guillen-Diaz; Cristina Pimenta; Dulce Diaz-Sosa; Kelika A Konda; Alessandro Ricardo Caruso da Cunha; Rebeca Robles-Garcia; Marcos Benedetti; Brenda Hoagland; Daniel R B Bezerra; Carlos F Caceres; Beatriz Grinsztejn; Valdilea G Veloso Journal: BMC Health Serv Res Date: 2022-04-22 Impact factor: 2.908
Authors: Samuel R Bunting; Brian A Feinstein; Sarah K Calabrese; Aniruddha Hazra; Neeral K Sheth; Alex F Chen; Sarah S Garber Journal: PLoS One Date: 2022-07-01 Impact factor: 3.752